Stryker shares tumble despite strong Q2 results and raised guidance

Published 31/07/2025, 23:02
Stryker shares tumble despite strong Q2 results and raised guidance

Investing.com -- Medical (TASE:BLWV) technology company Stryker Corporation (NYSE:SYK) reported second-quarter earnings that exceeded analyst expectations, but shares tumbled 4.7% as investors appeared to focus on concerns beyond the headline numbers.

The company posted adjusted earnings per share of $3.13 for the second quarter, beating the analyst estimate of $3.07. Revenue came in at $6.02 billion, surpassing the consensus estimate of $5.94 billion and representing an 11.1% increase compared to the same quarter last year. Organic sales growth was robust at 10.2%, driven primarily by a 9.7% increase in unit volume.

Despite the strong performance and raised full-year guidance, Stryker’s stock declined significantly in trading following the announcement. The company’s MedSurg and Neurotechnology segment showed particular strength, with sales increasing 17.3% to $3.8 billion, while Orthopaedics sales rose 2.0% to $2.2 billion.

"We again delivered double-digit sales and adjusted earnings per share growth in the second quarter," said Kevin A. Lobo, Chair and CEO. "Our strong sales and earnings power reflect demand for our products, our durable innovation pipeline and ongoing operational execution."

Stryker raised its full-year 2025 outlook, now expecting organic net sales growth of 9.5% to 10.0% and adjusted earnings per share between $13.40 and $13.60, above the analyst consensus of $13.36. The midpoint of this guidance ($13.50) represents a $0.14 increase over the analyst estimate.

The company also noted that it now estimates a net impact from tariffs in 2025 of approximately $175 million, reflecting recent changes in bilateral United States and China tariffs as well as the proposed tariff framework between the United States and the European Union.

Stryker’s adjusted operating income margin increased 110 basis points to 25.7% compared to the same quarter last year, demonstrating improved operational efficiency despite ongoing market challenges.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.